About DyAnsys
DyAnsys is a Healthcare company based in Chennai (India) founded in 2001. Portfolio of stimulation and monitoring systems for Pain, Diabetes and Cardiology markets. The company has 1 employees. Its Indian entity Neurostimulation Medtech Private Limited reported revenue of ₹4.70 Cr. DyAnsys offers products and services including First Relief®, Drug Relief®, Primary Relief®, ANSiscope®, and ECScope 100™. Its focus areas include Diversified Medical Devices.
Company details
Founded in 2001 and based in Chennai, India, the company operates in the medical device sector, focusing on applications in chronic and acute pain, diabetes, anesthesiology, cardiology, and autonomic dysfunction measurement. Products such as the ANSiStim miniaturized auricular stimulation device, the Portable ANSiscope non-invasive autonomic nervous system monitor, and the ECScope 100 series portable ECG recorders are offered for clinical use.
- Headquarters Chennai, India
- Employees 1
- SectorsHealthcare
- Email••••••••
- Website dyansys.com
- Social LinkedIn X Facebook YouTube
- Legal Name Dyansys India Private Limited
- Date of Incorporation 17 Jun, 2005
- Jurisdiction Chennai, Tamil Nadu, India
- Annual Revenue₹4.70 Cr
FY 2025 · +161% YoY
- Net Profit₹2.95 Cr
FY 2025 · 63% margin
- EBITDA₹2.95 Cr
FY 2025 · 63% margin
- Employee Count1
Associated legal entities of DyAnsys
DyAnsys operates through Neurostimulation Medtech Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Neurostimulation Medtech Private Limited CIN U33112TN2005PTC056638 | Active | 17 Jun 2005 | Chennai, Tamil Nadu | ₹4.7 Cr | 1 | 2 | View details |
Products & Services of DyAnsys
DyAnsys offers a comprehensive portfolio of products and services, including First Relief®, Drug Relief®, Primary Relief®, ANSiscope®, and ECScope 100™.
Manages neuropathic and abdominal pain safely and effectively.
Assists in opioid withdrawal with non-narcotic support.
Handles post-operative pain without harmful side effects.
Monitors autonomic nervous system for clinical applications.
Provides electrocardiogram for cardiac and autonomic health.
Apps and channels of DyAnsys
its YouTube channel DyAnsys has 78 subscribers and 15 videos.
Videos from DyAnsys
The most watched videos on DyAnsys's YouTube channel, DyAnsys (78 subscribers). Click a video to play it here.
More on DyAnsys.
Board of directors of Neurostimulation Medtech Private Limited (DyAnsys)
Neurostimulation Medtech Private Limited is the primary company behind DyAnsys. The board of Neurostimulation Medtech Private Limited currently have 2 directors; the longest-serving is Kytharam Naryanaiyer Narayanan, appointed in 2023. 9 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Kytharam Naryanaiyer Narayanan DIN 01543391 | Director | 20 May 2023 | 3 yrs 5 mo | Neurostimulation Medtech Private Limited |
| Rajan Srikanth DIN 02278258 | Director | 28 May 2024 | 2 yrs 4 mo | Neurostimulation Medtech Private Limited |
Financials of DyAnsys
Figures of Neurostimulation Medtech Private Limited, the primary company behind DyAnsys, for FY 2025. Revenue was ₹4.70 Cr (+161% year on year). Net profit was ₹2.95 Cr (63% margin). EBITDA was ₹2.95 Cr (63% margin). Revenue has grown at a compounded annual rate of +40% over three years and +36% over five years.
- ₹4.70 CrRevenue · FY 2025 · +161% YoY
- ₹2.95 CrNet profit · 63% margin
- ₹2.95 CrEBITDA · 63% margin
- ₹4.13 CrPaid-up capital
- 1Employees (provident fund records)
- +40%Revenue CAGR, 3 years
- +36%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Neurostimulation Medtech Private Limited are on its company page.
Detailed financial statements for DyAnsys
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Web traffic of DyAnsys
The website of DyAnsys (dyansys.com) receives about 2.3K visits a month.
- Monthly visits2.3K
▼ 2.3% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Dyansys
Complete news archive for DyAnsys
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about DyAnsys
DyAnsys was founded in 2001.
DyAnsys is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.
DyAnsys has 1 employees.
The primary company behind DyAnsys, Neurostimulation Medtech Private Limited, reported revenue of â‚ą4.70 Cr for FY 2025, up 161% year on year.
Founded in 2001 and based in Chennai, India, the company operates in the medical device sector, focusing on applications in chronic and acute pain, diabetes, anesthesiology, cardiology, and autonomic dysfunction measurement. Products such as the ANSiStim miniaturized auricular stimulation device, the Portable ANSiscope non-invasive autonomic nervous system monitor, and the ECScope 100 series portable ECG recorders are offered for clinical use.
DyAnsys offers First Relief®, Drug Relief®, Primary Relief®, ANSiscope®, and ECScope 100™.
DyAnsys operates through Neurostimulation Medtech Private Limited.
The legal entities of DyAnsys currently have 2 directors, including Kytharam Naryanaiyer Narayanan, Rajan Srikanth.